South and Central America Anaphylaxis Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)

No. of Pages: 136    |    Report Code: TIPRE00023955    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South and Central America Anaphylaxis Treatment Market

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Anaphylaxis Treatment Market – By Medication Type

1.3.2          Anaphylaxis Treatment Market – By Route of Administration

1.3.3          Anaphylaxis Treatment Market – By Allergy Type

1.3.4          Anaphylaxis Treatment Market – By Distribution Channel

1.3.5          South and Central America Anaphylaxis Treatment Market – By Country

2.           South and Central America Anaphylaxis Treatment Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           South and Central America Anaphylaxis Treatment Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Anaphylaxis Treatment Market- South and Central America PEST Analysis

4.3          Expert Opinion

5.           South and Central America Anaphylaxis Treatment Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Rising Incidence of Anaphylaxis

5.1.2          Recent Approvals for Epinephrine

5.2          Market Restraints

5.2.1          Poor Access to Epinephrine Auto-Injectors in Low-Income Countries

5.3          Market Opportunities

5.3.1          Rise in Cases of Allergies Post Administration of COVID-19 Vaccines

5.4          Future Trends

5.4.1          Novel Drug Delivery Systems

5.5          Impact Analysis

6.           Anaphylaxis Treatment Market – South and Central America Analysis

6.1          South and Central America Anaphylaxis Treatment Market Revenue Forecasts and Analysis

7.           South and Central America Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Medication Type

7.1          Overview

7.2          Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)

7.3          Epinephrine

7.3.1          Overview

7.3.2          Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Antihistamines

7.4.1          Overview

7.4.2          Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Steroids

7.5.1          Overview

7.5.2          Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Beta-Agonist

7.6.1          Overview

7.6.2          Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.           Anaphylaxis Treatment Market Analysis – By Route of Administration

8.1          Overview

8.2          Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)

8.3          Oral

8.3.1          Overview

8.3.2          Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Parenteral

8.4.1          Overview

8.4.2          Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Others

8.5.1          Overview

8.5.2          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.           South and Central America Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Allergy Type

9.1          Overview

9.2          Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)

9.3          Food Allergy

9.3.1          Overview

9.3.2          Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Medications

9.4.1          Overview

9.4.2          Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Insect Stings

9.5.1          Overview

9.5.2          Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.        South and Central America Anaphylaxis Treatment Market Analysis and Forecasts to 2028– By Distribution Channel

10.1        Overview

10.2        Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)

10.3        Retail Sales

10.3.1        Overview

10.3.2        Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

10.4        Hospital Pharmacies

10.4.1        Overview

10.4.2        Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

10.5        Others

10.5.1        Overview

10.5.2        Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)

11.        Anaphylaxis Treatment Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1        South and Central America: Anaphylaxis Treatment Market

11.1.1        Overview

11.1.2        South and Central America: Anaphylaxis Treatment Market Share by Country – 2020 & 2028, (%)

11.1.2.1          Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.1.2.1.1           Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.1.2.1.2           Brazil: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)

11.1.2.1.3           Brazil: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.2.1.4           Brazil: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.2.1.5           Brazil: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)

11.1.2.1.6           Brazil: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)

11.1.2.2          Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.1.2.2.1           Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.1.2.2.2           Argentina: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)

11.1.2.2.3           Argentina: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.2.2.4           Argentina: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.2.2.5           Argentina: Anaphylaxis Treatment Market, by Allergy Type, 2019 -2028 (USD Million)

11.1.2.2.6           Argentina: Anaphylaxis Treatment Market, by Distribution Channel, 2019 -2028 (USD Million)

11.1.2.3          Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.1.2.3.1           Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.1.2.3.2           Rest of South and Central America: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)

11.1.2.3.3           Rest of South and Central America: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.2.3.4           Rest of South and Central America: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.2.3.5           Rest of South and Central America: Anaphylaxis Treatment Market, by Allergy Type, 2018-2027 (USD Million)

11.1.2.3.6           Rest of South and Central America: Anaphylaxis Treatment Market, by Distribution Channel, 2018-2027 (USD Million)

12.        Impact Of COVID-19 Pandemic on South and Central America Anaphylaxis Treatment Market

12.1        South and Central America: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1        Overview

13.2        Growth Strategies Done by the Companies in the Market, (%)

13.3        Organic Developments

13.3.1        Overview

13.4        Inorganic Developments

13.4.1        Overview

14.        COMPANY PROFILES

14.1        Abbott

14.1.1        Key Facts

14.1.2        Business Description

14.1.3        Products and Services

14.1.4        Financial Overview

14.1.5        SWOT Analysis

14.1.6        Key Developments

14.2        ALK-Abelló A/S

14.2.1        Key Facts

14.2.2        Business Description

14.2.3        Products and Services

14.2.4        Financial Overview

14.2.5        SWOT Analysis

14.2.6        Key Developments

14.3        Amneal Pharmaceuticals, Inc.

14.3.1        Key Facts

14.3.2        Business Description

14.3.3        Products and Services

14.3.4        Financial Overview

14.3.5        SWOT Analysis

14.3.6        Key Developments

14.4        GlaxoSmithKline plc.

14.4.1        Key Facts

14.4.2        Business Description

14.4.3        Products and Services

14.4.4        Financial Overview

14.4.5        SWOT Analysis

14.4.6        Key Developments

14.5        Merck & Co., Inc.

14.5.1        Key Facts

14.5.2        Business Description

14.5.3        Products and Services

14.5.4        Financial Overview

14.5.5        SWOT Analysis

14.5.6        Key Developments

14.6        MYLAN N.V.

14.6.1        Key Facts

14.6.2        Business Description

14.6.3        Products and Services

14.6.4        Financial Overview

14.6.5        SWOT Analysis

14.6.6        Key Developments

14.7        Pfizer Inc.

14.7.1        Key Facts

14.7.2        Business Description

14.7.3        Products and Services

14.7.4        Financial Overview

14.7.5        SWOT Analysis

14.7.6        Key Developments

14.8        TEVA PHARMACEUTICAL INDUSTRIES LTD

14.8.1        Key Facts

14.8.2        Business Description

14.8.3        Products and Services

14.8.4        Financial Overview

14.8.5        SWOT Analysis

14.8.6        Key Developments

15.        Appendix

15.1        About the Insight Partners

15.2        Glossary of Terms

 

LIST OF TABLES

Table 1.              Brazil: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              Brazil: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 3.              Brazil: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 4.              Brazil: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 5.              Brazil Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 6.              Argentina: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 7.              Argentina: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 8.              Argentina: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 9.              Argentina: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 10.            Argentina Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.            Rest of South and Central America: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 12.            Rest of South and Central America: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 13.            Rest of South and Central America: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 14.            Rest of South and Central America: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 15.            Rest of South and Central America Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 16.            Organic Developments Done by Companies

Table 17.            Inorganic Developments Done by Companies

Table 18.            Glossary of Terms, Anaphylaxis Treatment Market


LIST OF FIGURES

Figure 1.            Anaphylaxis Treatment Market Segmentation

Figure 2.            South and Central America Anaphylaxis Treatment Market Overview

Figure 3.            Epinephrine Segment Held Largest Share of Medication Type in Anaphylaxis Treatment Market

Figure 4.            Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Anaphylaxis Treatment Market - South and Central America PEST Analysis

Figure 6.            Anaphylaxis Treatment Market Impact Analysis of Driver and Restraints

Figure 7.            South and Central America Anaphylaxis Treatment Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)

Figure 9.            Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)

Figure 15.          Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.          Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)

Figure 19.          Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.          Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)

Figure 24.          Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 25.          Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 26.          Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)

Figure 27.          South and Central America: Anaphylaxis Treatment Market, By Key Country – Revenue (2020) (USD Million)

Figure 28.          South and Central America: Anaphylaxis Treatment Market Share by Country – 2020 & 2028, (%)

Figure 29.          Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)

Figure 30.          Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)

Figure 31.          Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)

Figure 32.          Impact of COVID-19 Pandemic in South and Central America Country Markets

Figure 33.          Growth Strategies Done by the Companies in the Market, (%)

 

 

The List of Companies - South and Central America Anaphylaxis Treatment Market

  1. Amneal Pharmaceuticals Inc.
  2. Mylan N.V.
  3. Abbott
  4. Pfizer Inc.
  5. Glaxosmithkline Plc.,
  6. Merck And Co., Inc.
  7. Teva Pharmaceutical Industries Ltd.        
  8. ALK-ABELLó